CStone Pharmaceuticals (2616.HK)

Healthcare | Biotechnology
Income Statement (Quarterly) 2026-04-07 2025-06-30 2025-03-31 2024-12-31
Revenue 24,725,500 24,725,500 24,725,500 76,520,000
Cost of Revenue 71,120,500 71,120,500 71,120,500 42,457,500
Gross Profit -46,395,000 -46,395,000 -46,395,000 34,062,500
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 39,600,000 39,600,000 39,600,000 51,069,500
Operating Expenses 92,183,000 92,183,000 92,183,000 85,274,000
Operating Income -138,578,000 -138,578,000 -138,578,000 -51,211,500
Interest Expense 0 2,910,500 0 0
Income Before Tax -135,091,500 -135,091,500 -135,091,500 -53,453,000
Income Tax Expense 0 0 0 0
Net Income -135,091,500 -135,091,500 -135,091,500 -53,453,000
Per Share
EPS -0.10 -0.10 -0.10 -0.04
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2023-06-30 2022-12-31 2021-12-31
Revenue 407,205,000 463,842,000 0 481,363,000 243,718,000
Cost of Revenue 167,051,000 159,547,000 0 202,985,000 106,832,000
Gross Profit 240,154,000 304,295,000 0 278,378,000 136,886,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 166,943,000 248,065,000 0 390,476,000 472,992,000
Operating Expenses 331,846,000 304,295,000 0 1,181,886,000 1,930,359,000
Operating Income -91,692,000 -534,607,000 0 -832,272,000 -1,793,473,000
Interest Expense 15,167,000 11,819,000 0 8,477,000 2,242,000
Income Before Tax -91,207,000 -367,234,000 0 -902,678,000 -1,920,100,000
Income Tax Expense 0 0 0 61,929,000 0
Net Income -91,207,000 -367,234,000 0 -964,607,000 -1,920,100,000
Per Share
EPS -0.07 -0.29 0.00 -0.82 -1.65
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Cash and Cash Equivalents 387,937,000 996,671,000 558,684,000 742,724,000
Short Term Investments 285,000,000 30,000,000 483,407,000 983,615,000
Net Receivables 130,875,000 172,438,000 77,133,000 0
Inventory 286,096,000 108,828,000 22,188,000 61,363,000
Total Current Assets 1,089,908,000 1,329,787,000 1,246,917,000 1,957,645,000
Property Plant Equipment 130,543,000 153,368,000 206,566,000 187,923,000
Goodwill and Intangibles 161,366,000 173,045,000 159,699,000 70,539,000
Total Assets 1,393,466,000 1,661,999,000 1,638,427,000 2,271,453,000
Liabilities
Account Payables 338,029,000 246,377,000 290,414,000 33,024,000
Short Term Debt 93,216,000 139,313,000 44,918,000 43,948,000
Total Current Liabilities 682,006,000 850,338,000 946,482,000 932,948,000
Long Term Debt 262,757,000 224,135,000 241,372,000 130,250,000
Total Liabilities 1,029,595,000 1,205,169,000 1,189,101,000 1,064,445,000
Shareholders Equity
Retained Earnings 0 -9,019,727,000 -8,652,493,000 0
Total Shareholders Equity 363,871,000 456,830,000 449,326,000 1,207,008,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Assets
Cash and Cash Equivalents 387,937,000 996,671,000 558,684,000 742,724,000 3,024,548,000
Short Term Investments 285,000,000 30,000,000 483,407,000 983,615,000 368,995,000
Net Receivables 130,875,000 172,438,000 77,133,000 0 0
Inventory 286,096,000 108,828,000 22,188,000 61,363,000 0
Total Current Assets 1,089,908,000 1,329,787,000 1,246,917,000 1,957,645,000 3,572,303,000
Property Plant Equipment 130,543,000 153,368,000 206,566,000 187,923,000 101,953,000
Goodwill and Intangibles 161,366,000 173,045,000 159,699,000 70,539,000 6,509,000
Total Assets 1,393,466,000 1,661,999,000 1,638,427,000 2,271,453,000 3,762,752,000
Liabilities
Account Payables 338,029,000 246,377,000 290,414,000 33,024,000 28,030,000
Short Term Debt 93,216,000 139,313,000 44,918,000 43,948,000 11,314,000
Total Current Liabilities 682,006,000 850,338,000 946,482,000 932,948,000 727,049,000
Long Term Debt 262,757,000 224,135,000 241,372,000 130,250,000 72,545,000
Total Liabilities 1,029,595,000 1,205,169,000 1,189,101,000 1,064,445,000 808,292,000
Shareholders Equity
Retained Earnings 0 -9,019,727,000 -8,652,493,000 0 0
Total Shareholders Equity 363,871,000 456,830,000 449,326,000 1,207,008,000 2,954,460,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Activities
Net Income -91,207,000 -367,234,000 -902,678,000 -1,920,100,000
Depreciation & Amortization 49,805,000 58,190,000 44,540,000 22,661,000
Stock Based Compensation -2,811,000 36,993,000 142,062,000 222,671,000
Change in Working Capital -302,800,000 -140,814,000 72,647,000 64,520,000
Operating Cash Flow -343,181,000 -588,843,000 -612,469,000 -1,484,024,000
Investing Activities
Capital Expenditure 0 -65,047,000 -101,821,000 -149,136,000
Investments 0 -15,000 -101,821,000 -91,026,000
Investing Cash Flow -247,679,000 619,605,000 365,119,000 -826,552,000
Financing Activities
Debt Repayment -786,000 91,433,000 -32,000,000 -6,706,000
Common Stock Issued/Repurchased 74,000 341,824,000 2,529,000 16,830,000
Dividends Paid 0 0 0 0
Financing Cash Flow -12,896,000 388,355,000 28,467,000 92,304,000
Summary
Free Cash Flow -343,181,000 -653,890,000 -714,290,000 -1,633,160,000
Net Change in Cash -608,734,000 437,987,000 -184,040,000 -2,281,824,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Operating Activities
Net Income -91,207,000 -367,234,000 -902,678,000 -1,920,100,000 -1,220,999,000
Depreciation & Amortization 49,805,000 58,190,000 44,540,000 22,661,000 14,801,000
Stock Based Compensation -2,811,000 36,993,000 142,062,000 222,671,000 356,023,000
Change in Working Capital -302,800,000 -140,814,000 72,647,000 64,520,000 185,978,000
Operating Cash Flow -343,181,000 -588,843,000 -612,469,000 -1,484,024,000 -508,070,000
Investing Activities
Capital Expenditure 0 -65,047,000 -101,821,000 -149,136,000 -71,446,000
Investments 0 -15,000 -101,821,000 -91,026,000 -67,039,000
Investing Cash Flow -247,679,000 619,605,000 365,119,000 -826,552,000 1,180,732,000
Financing Activities
Debt Repayment -786,000 91,433,000 -32,000,000 -6,706,000 -1,580,000
Common Stock Issued/Repurchased 74,000 341,824,000 2,529,000 16,830,000 1,339,128,000
Dividends Paid 0 0 0 0 0
Financing Cash Flow -12,896,000 388,355,000 28,467,000 92,304,000 1,389,429,000
Summary
Free Cash Flow -343,181,000 -653,890,000 -714,290,000 -1,633,160,000 -579,516,000
Net Change in Cash -608,734,000 437,987,000 -184,040,000 -2,281,824,000 1,898,112,000